EBITDA rebound in H1 2026; execution of the f...

Eramet posts strong EBITDA growth but still relies on a major capital raise.

What the company is saying

Eramet frames its H1 2026 results as a financial turnaround, highlighting a 45% jump in adjusted EBITDA to €276m and a return to breakeven free cash flow. The narrative credits these improvements to higher lithium and manganese volumes and cost savings from the ReSolution programme, but does not quantify each driver. Management emphasizes strict capex discipline and working capital rigor, presenting these as evidence of operational control. The announcement repeatedly labels the €500m capital increase, approved for Q4 2026, as essential to the funding plan, underlining its centrality to future stability. Operational updates—such as a 6% lift in Gabonese manganese volumes, 90% lithium plant utilization in Argentina, and a partial restart in Senegal—are presented as proof points of recovery and resilience. The tone is measured, with forward-looking statements about production targets and a return to full capacity in Senegal by Q1 2027, but avoids overtly promotional language.

What the data suggests

Headline financials confirm a marked improvement: adjusted EBITDA rose 45% to €276m, and free cash flow swung from -€266m to +€7m. Net debt fell by €67m to €1,868m, and liquidity stands at €1.3bn, though this includes a fully drawn €935m revolving credit facility. Net income remains negative at -€146m, driven by a €112m impairment on Senegalese mineral sands after a fire and reserve update. Capex dropped 53% to €100m, with €35m earmarked for Gabon and €16m for Senegal. Operationally, manganese ore transport in Gabon increased 6%, lithium output in Argentina hit 90% of nameplate in June, and mineral sands in Senegal partially restarted with €50m in insurance proceeds. The data supports the turnaround narrative for EBITDA and cash flow but reveals continued bottom-line losses and heavy reliance on external funding. Several claims—such as the impact of management initiatives or operational improvements—are asserted without numerical breakdowns, limiting visibility into underlying drivers.

Analysis

The announcement presents a balanced tone, with most headline claims supported by concrete, realised financial and operational data (e.g., adjusted EBITDA up 45%, Free Cash-Flow breakeven, net debt reduction). Forward-looking statements (such as production targets and the capital increase execution) are clearly separated from realised results and are not exaggerated in language. The capital intensity flag is triggered by the €500m capital increase, which is approved but not yet executed, and whose benefits (funding plan completion, future growth) are not immediate. However, the company discloses both profitability (EBITDA, net income) and cash flow metrics, though net income remains negative. The gap between narrative and evidence is minimal: while some claims about operational improvements and programme savings lack granular breakdowns, the overall message is proportionate to the disclosed results. There is no evidence of narrative inflation or overstatement.

Risk flags

• ●The €500m capital increase, while approved, is not yet executed and is described as essential to the funding plan. Failure to complete this raise would leave the company exposed to liquidity and refinancing risk, especially given high net debt and a fully drawn RCF.
• ●Net income remains negative at -€146m, even after a strong EBITDA rebound, due to a €112m impairment in Senegal. This signals ongoing vulnerability to operational disruptions and asset write-downs, which could recur if further incidents or reserve downgrades occur.
• ●Operational claims—such as productivity gains from the ReSolution programme and improvements in rail transport—are not quantified, making it difficult to assess their sustainability or impact. This lack of granularity reduces confidence in the durability of recent gains.
• ●The company’s liquidity position, while headline-strong at €1.3bn, is heavily reliant on a fully drawn €935m RCF. This concentration of short-term debt increases refinancing pressure if market conditions tighten before the capital raise is completed.
• ●Forward-looking targets for production and cost improvements are contingent on successful project execution in multiple geographies (Senegal, Gabon, Argentina), each with distinct operational and geopolitical risks. Delays or setbacks in any region could undermine guidance.

Bottom line

Eramet’s H1 2026 results show a clear rebound in EBITDA and cash flow, but the company is still loss-making at the net income level and remains highly leveraged. The planned €500m capital increase in Q4 2026 is pivotal; until it is completed, funding risk persists. While operational recovery is underway—especially in manganese and lithium—key claims about cost savings and productivity lack detailed evidence. The company’s liquidity headline is flattered by reliance on short-term debt, and asset impairments highlight ongoing operational risk. For investors, the story is one of partial recovery but not yet full financial health. The most important factor to watch is the execution of the capital raise and delivery on production ramp-ups; without these, the turnaround remains incomplete.

Announcement summary

(LSE/AIM:0MGV) Eramet reported an adjusted EBITDA of €276m for H1 2026, up 45% from €191m in H1 2025, driven by growth in lithium and manganese volumes and savings under the ReSolution programme. Adjusted Free Cash-Flow returned to breakeven at +€7m, compared to -€266m in H1 2025, reflecting the EBITDA rebound, strict capex discipline, and rigorous WCR management. Net income, Group share (excluding SLN), was -€146m after an impairment of Mineral Sands assets amounting to -€112m following a fire and an update of mineral reserves in Senegal. Net debt (Net cash) stood at €1,868m as of 30 June 2026, down from €1,935m at 31 December 2025, and liquidity was €1.3bn, including a fully drawn RCF of €935m. A €500m capital increase was approved at the General Meeting in May 2026, with execution planned for Q4 2026 and deemed essential to the funding plan. The company projects manganese ore transported at 6.4 - 6.8 Mt, lithium carbonate at 17 - 20 kt-LCE, nickel ore sold externally at 9 Mwmt, and Mineral Sands at 300 - 400 kt-HMC, with a return to full capacity planned for Q1 2027. Capex is targeted between €250m and €290m, including €35m for repairs in Senegal.

Disagree with this article?